Skip to main content
  • Gender No Predictor of Prolonged DAPT Benefit No clear survival benefit for either sex, as well

    Prolonged dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) effects don’t differ by gender, the PRODIGY investigators suggested.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details